Results 121 to 130 of about 7,182,421 (220)

Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease. [PDF]

Blood Adv, 2023
Afangbedji N, Kumari N, Diaz S, Wen F, Taylor JG, Nekhai S, Jerebtsova M.   +6 more
europepmc   +1 more source

Protective effect of Maixuekang on renal function in rats with unilateral ureteral obstruction and its underlying mechanism

Linchuang shenzangbing zazhi, 2016
Objective To observe the protective effect of Maixuekang on renal function in rats with unilateral ureteral obstruction(UUO),and to investigate the possible mechanism.Methods UUO model was established.Rats were divided into three groups:sham operation ...
LIANG Jing, ZHANG Yuan, CHEN Kai-feng, CAO Ling   +3 more
doaj  

The accuracy of soluble urokinase-type plasminogen activator receptor for the diagnosis of neonatal sepsis: a meta-analysis. [PDF]

Front Med (Lausanne), 2023
Ma J, Chen X, Wang X, Liang J, Guo L, Su Y, Hao L, Ren C.   +7 more
europepmc   +1 more source

Inhibition of urokinase-type and tissue-type plasminogen activator - Mediated plasminogen activation by doxycycline

, 1996
Degradation and remodelling of the extracellular matrix is an essential feature in many pathophysiological processes, especially in invasive and angiogenesis-related diseases.
Hanemaaijer, R., Sorsa, T., Hoogen, C.M. van den, Hinsbergh, V.W.M. van, Visser, H.   +4 more
core  

Potential Role of the Urokinase-Type Plasminogen Activator Receptor-Integrin β3 Axis in Podocyte Adhesion Instability and Loss. [PDF]

Kidney Int Rep
Kim JH, Dang BTN, Kim J, Eom M, Cha SK, Kim J.   +5 more
europepmc   +1 more source

The Relationship Between Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Treatment Response in Patients With Glomerulonephritis: A Single-Center Experience. [PDF]

Cureus, 2023
İşsever K, Dheir H.
europepmc   +1 more source

Polypeptide inhibitors of urokinase type plasminogen activator

A conjugate which is capable of specific binding to and inhibition of urokinase-type plasminigen activator (UPA) comprising a polypeptide molecule and a scaffold molecule, wherein said polypeptide molecule is attached to said scaffold molecule by at ...
Winter, Greg, Angelini, Alessandro, Heinis, Christian   +2 more
core  

The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells

, 2000
Single-chain urokinase-type plasminogen activator (scu-PA) is cleaved by thrombin, resulting in an inactive molecule called thrombin-cleaved two-chain urokinase-type plasminogen activator (tcu-PA/T). There is no knowledge about cell-mediated inactivation
Collen, A., Rijken, D.C., Grimbergen, J.M., Jie, A.F.H., Braat, E.A.M.   +4 more
core  

Cord blood procalcitonin and soluble urokinase-type plasminogen activator receptor in predicting histological chorioamnionitis - A pilot study. [PDF]

Eur J Obstet Gynecol Reprod Biol X
Jalkanen K, Tammela O, Virtanen A, Aittoniemi J, Flinck H, Ampuja S, Huhtala H, Tihtonen K.   +7 more
europepmc   +1 more source

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]

Neuromolecular Med
de Rezende VL, Mathias K, Danielski LG, Barichello T, Petronilho F.   +4 more
europepmc   +1 more source